Cellsway Alternatives & Competitors

12 companies similar to Cellsway — Liquid biopsy for cancer monitoring through isolation and counting Circulating T...

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

224 Acquired $8.43B

Redwood City, United Stat...

Biopharma Biotechnology +3

NiKang Therapeutics Inc.

37 Series C $260.00M

Wilmington, United States

Biotechnology Health Care

Alterome Therapeutics, Inc

To Life!

43 Series B $231.00M

San Diego, United States

Biopharma Biotechnology +1

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 Acquired $4.78B

San Diego, United States

Biotechnology Health Care +2

Track all Cellsway competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Crossbow Therapeutics, Inc

Established antibody engineering to target the untapped universe of intracellular cancer t...

45 Series B $157.00M

Cambridge, United States

Biotechnology Health Care +1

Hedera Dx

Modern cancer care to the next billion people

31 Series A $29.00M

Epalinges, Switzerland

Health Care

Exelixis

Exelixis works on discovering, developing, and commercializing therapies for the treatment...

1566 IPO $340.26M

Alameda, United States

Biotechnology

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

Convergent Therapeutics, Inc.

Developing next-generation targeted combination therapies to advance the care of cancer pa...

39 Series A $132.50M

Cambridge, United States

Exai Bio

Delivering next-generation liquid biopsy platform for the earliest detection and most accu...

22 Unknown $138.96M

Palo Alto, United States

Biotechnology Health Care

ImmunoGen

Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...

34 Acquired $681.30M

Biotechnology Health Care +1

Accutar Biotech

Employ AI to Revolutionize Drug Discovery

40 Series Unknown $77.45M

Brooklyn, United States

AI Biopharma +2

About Cellsway

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.

Services

CTC Enrichment Device, CTC Identification Panel, ER/PR/Her2 CTC Panel, PD-L1 CTC Panel

Target Customers

Cancer Patients, Oncologists, Clinical Laboratories, Research Institutions

Taxonomy

Liquid Biopsy, Cancer Monitoring, Circulating Tumor Cells, CTC Detection, Microfluidics, Lab-on-a-chip, Biomedical Technology, Cancer Diagnostics, Cancer Research, Minimally Invasive Technology, Blood Sample Analysis, Deep-tech Startup, Oncology, Precision Medicine, Patent-pending Technology

Business Model

B2B, D2C, B2D

Revenue Model

Product Sales, Service Fee, Usage Based

Frequently Asked Questions

Top alternatives to Cellsway include Arcellx, NiKang Therapeutics Inc., Alterome Therapeutics, Inc, RayzeBio, Crossbow Therapeutics, Inc. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Cellsway based on industry overlap, target customers, and business model.

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.

Don't just read about them. Follow them.

BounceWatch watches Cellsway and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Cellsway Profile Arcellx Alternatives NiKang Therapeutics Inc. Alternatives Alterome Therapeutics, Inc Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Cellsway on 2 Sep 2026. The 12 companies listed here were last checked between 13 Nov 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.